← All Representatives

Clay Higgins

House of Representatives · Rep · LA

Terms: from 3 January 2017 to 21 December 2018 ; from 3 January 2019 to 28 December 2020 ; from 3 January 2021 to 23 December 2022 ; from 4 January 2023 to 20 December 2024 ; since 3 January 2025

Participation in roll-call votes

94 % of the 5,054 roll-call votes held during their term: took part in the vote (for, against or abstention)

Participation month by month

0 % 50 % 100 % January 2017 : participation 100 % (67 / 67), presence 100 % (67 / 67) 2017 February 2017 : participation 100 % (39 / 39), presence 100 % (39 / 39) March 2017 : participation 99 % (99 / 100), presence 99 % (99 / 100) April 2017 : participation 100 % (28 / 28), presence 100 % (28 / 28) May 2017 : participation 100 % (49 / 49), presence 100 % (49 / 49) June 2017 : participation 97 % (57 / 59), presence 97 % (57 / 59) July 2017 : participation 97 % (91 / 94), presence 97 % (91 / 94) September 2017 : participation 97 % (102 / 105), presence 97 % (102 / 105) October 2017 : participation 100 % (48 / 48), presence 100 % (48 / 48) November 2017 : participation 98 % (57 / 58), presence 98 % (57 / 58) December 2017 : participation 95 % (58 / 61), presence 95 % (58 / 61) January 2018 : participation 100 % (48 / 48), presence 100 % (48 / 48) 2018 February 2018 : participation 100 % (41 / 41), presence 100 % (41 / 41) March 2018 : participation 97 % (37 / 38), presence 97 % (37 / 38) April 2018 : participation 100 % (37 / 37), presence 100 % (37 / 37) May 2018 : participation 63 % (40 / 64), presence 63 % (40 / 64) June 2018 : participation 100 % (83 / 83), presence 100 % (83 / 83) July 2018 : participation 100 % (66 / 66), presence 100 % (66 / 66) September 2018 : participation 100 % (36 / 36), presence 100 % (36 / 36) November 2018 : participation 100 % (10 / 10), presence 100 % (10 / 10) December 2018 : participation 100 % (75 / 75), presence 100 % (75 / 75) January 2019 : participation 100 % (63 / 63), presence 100 % (63 / 63) 2019 February 2019 : participation 100 % (38 / 38), presence 100 % (38 / 38) March 2019 : participation 100 % (33 / 33), presence 100 % (33 / 33) April 2019 : participation 89 % (31 / 35), presence 89 % (31 / 35) May 2019 : participation 87 % (52 / 60), presence 87 % (52 / 60) June 2019 : participation 99 % (198 / 199), presence 99 % (198 / 199) July 2019 : participation 50 % (42 / 84), presence 50 % (42 / 84) September 2019 : participation 63 % (26 / 41), presence 63 % (26 / 41) October 2019 : participation 96 % (52 / 54), presence 96 % (52 / 54) November 2019 : participation 100 % (33 / 33), presence 100 % (33 / 33) December 2019 : participation 98 % (58 / 59), presence 98 % (58 / 59) January 2020 : participation 64 % (21 / 33), presence 64 % (21 / 33) 2020 February 2020 : participation 100 % (44 / 44), presence 100 % (44 / 44) March 2020 : participation 100 % (24 / 24), presence 100 % (24 / 24) April 2020 : participation 100 % (2 / 2), presence 100 % (2 / 2) May 2020 : participation 100 % (11 / 11), presence 100 % (11 / 11) June 2020 : participation 100 % (18 / 18), presence 100 % (18 / 18) July 2020 : participation 98 % (44 / 45), presence 98 % (44 / 45) August 2020 : participation 0 % (0 / 4), presence 0 % (0 / 4) September 2020 : participation 100 % (31 / 31), presence 100 % (31 / 31) October 2020 : participation 100 % (5 / 5), presence 100 % (5 / 5) November 2020 : participation 100 % (9 / 9), presence 100 % (9 / 9) December 2020 : participation 62 % (16 / 26), presence 62 % (16 / 26) January 2021 : participation 94 % (15 / 16), presence 94 % (15 / 16) 2021 February 2021 : participation 97 % (30 / 31), presence 97 % (30 / 31) March 2021 : participation 98 % (47 / 48), presence 98 % (47 / 48) April 2021 : participation 97 % (35 / 36), presence 97 % (35 / 36) May 2021 : participation 96 % (22 / 23), presence 96 % (22 / 23) June 2021 : participation 58 % (28 / 48), presence 58 % (28 / 48) July 2021 : participation 8 % (4 / 50), presence 8 % (4 / 50) August 2021 : participation 100 % (6 / 6), presence 100 % (6 / 6) September 2021 : participation 98 % (51 / 52), presence 98 % (51 / 52) October 2021 : participation 89 % (24 / 27), presence 89 % (24 / 27) November 2021 : participation 98 % (48 / 49), presence 98 % (48 / 49) December 2021 : participation 84 % (51 / 61), presence 84 % (51 / 61) January 2022 : participation 38 % (5 / 13), presence 38 % (5 / 13) 2022 February 2022 : participation 100 % (34 / 34), presence 100 % (34 / 34) March 2022 : participation 100 % (54 / 54), presence 100 % (54 / 54) April 2022 : participation 95 % (37 / 39), presence 95 % (37 / 39) May 2022 : participation 96 % (87 / 91), presence 96 % (87 / 91) June 2022 : participation 100 % (67 / 67), presence 100 % (67 / 67) July 2022 : participation 97 % (114 / 118), presence 97 % (114 / 118) August 2022 : participation 100 % (3 / 3), presence 100 % (3 / 3) September 2022 : participation 100 % (57 / 57), presence 100 % (57 / 57) November 2022 : participation 100 % (14 / 14), presence 100 % (14 / 14) December 2022 : participation 100 % (58 / 58), presence 100 % (58 / 58) January 2023 : participation 99 % (83 / 84), presence 99 % (83 / 84) 2023 February 2023 : participation 96 % (23 / 24), presence 96 % (23 / 24) March 2023 : participation 100 % (58 / 58), presence 100 % (58 / 58) April 2023 : participation 100 % (20 / 20), presence 100 % (20 / 20) May 2023 : participation 100 % (42 / 42), presence 100 % (42 / 42) June 2023 : participation 100 % (45 / 45), presence 100 % (45 / 45) July 2023 : participation 98 % (91 / 93), presence 98 % (91 / 93) September 2023 : participation 100 % (131 / 131), presence 100 % (131 / 131) October 2023 : participation 97 % (36 / 37), presence 97 % (36 / 37) November 2023 : participation 99 % (130 / 131), presence 99 % (130 / 131) December 2023 : participation 94 % (33 / 35), presence 94 % (33 / 35) January 2024 : participation 97 % (28 / 29), presence 97 % (28 / 29) 2024 February 2024 : participation 100 % (29 / 29), presence 100 % (29 / 29) March 2024 : participation 93 % (42 / 45), presence 93 % (42 / 45) April 2024 : participation 99 % (66 / 67), presence 99 % (66 / 67) May 2024 : participation 97 % (59 / 61), presence 97 % (59 / 61) June 2024 : participation 97 % (100 / 103), presence 97 % (100 / 103) July 2024 : participation 29 % (19 / 65), presence 29 % (19 / 65) September 2024 : participation 98 % (54 / 55), presence 98 % (54 / 55) November 2024 : participation 100 % (23 / 23), presence 100 % (23 / 23) December 2024 : participation 95 % (37 / 39), presence 95 % (37 / 39) January 2025 : participation 100 % (25 / 25), presence 100 % (25 / 25) 2025 February 2025 : participation 92 % (24 / 26), presence 92 % (24 / 26) March 2025 : participation 100 % (32 / 32), presence 100 % (32 / 32) April 2025 : participation 100 % (27 / 27), presence 100 % (27 / 27) May 2025 : participation 94 % (31 / 33), presence 94 % (31 / 33) June 2025 : participation 100 % (40 / 40), presence 100 % (40 / 40) July 2025 : participation 85 % (28 / 33), presence 85 % (28 / 33) September 2025 : participation 100 % (64 / 64), presence 100 % (64 / 64) November 2025 : participation 100 % (23 / 23), presence 100 % (23 / 23) December 2025 : participation 100 % (57 / 57), presence 100 % (57 / 57) January 2026 : participation 98 % (46 / 47), presence 98 % (46 / 47) 2026 February 2026 : participation 100 % (30 / 30), presence 100 % (30 / 30) March 2026 : participation 97 % (29 / 30), presence 97 % (29 / 30) April 2026 : participation 96 % (45 / 47), presence 96 % (45 / 47) May 2026 : participation 100 % (36 / 36), presence 100 % (36 / 36) June 2026 : participation 95 % (40 / 42), presence 95 % (40 / 42) July 2026 : participation 94 % (47 / 50), presence 94 % (47 / 50) August 2026 : participation 100 % (2 / 2), presence 100 % (2 / 2) September 2026 : participation 100 % (29 / 29), presence 100 % (29 / 29) November 2026 : participation 100 % (13 / 13), presence 100 % (13 / 13)

Their votes

2,488 votes

DateTextResultTheir vote
H.Res. 403: Providing for consideration of H.R. 1629,the Fairness in Orphan Drug Exclusivity Act; and H. Res. 275, condemning the horrific shootings in Atlanta, GA on March 16, 2021 ✓ Adopted Absent
S. 937: COVID-19 Hate Crimes Act ✓ Adopted Against
H.R. 2911: VA Transparency & Trust Act ✓ Adopted For
H.R. 1065: Pregnant Workers Fairness Act ✓ Adopted Against
H.R. 2877: Behavioral Intervention Guidelines Act of 2021 ✓ Adopted For
H.R. 2547: Comprehensive Debt Collection Improvement Act ✓ Adopted Against
MOTION — On Motion to Suspend the Rules and Pass Certain Bills ✓ Adopted Against
H.Res. 380: Providing for consideration of the bill (H.R. 2547) Comprehensive Debt Collection Improvement Act; providing for consideration of the bill (H.R. 1065) Pregnant Workers Fairness Act and for other purposes ✓ Adopted Against
H.R. 1629: Fairness in Orphan Drug Exclusivity Act ✗ Rejected Against
H.R. 51: Washington, D.C. Admission Act ✓ Adopted Against
H.R. 1392: Protection of Saudi Dissidents Act ✓ Adopted Against
H.R. 1573: Access to Counsel Act ✓ Adopted Against
H.R. 1333: NO BAN Act ✓ Adopted Against
MOTION — On Motion to Suspend the Rules and Pass Certain Bills and Agree to a Resolution ✓ Adopted For
H.Res. 330: Providing for consideration of the bill (H.R. 51) Washington, D.C. Admission Act; providing for consideration of the bill (H.R. 1573) Access to Counsel Act; providing for consideration of the bill (H.R. 1333) NO BAN Act; and for other purposes ✓ Adopted Against
H.Res. 130: Condemning the continued violation of rights and freedoms of the people of Hong Kong by the People’s Republic of China and the Government of the Hong Kong Special Administrative Region ✓ Adopted For
H.R. 1996: SAFE Banking Act ✓ Adopted For
H.R. 1482: 504 Credit Risk Management Improvement Act ✓ Adopted For
H.R. 1195: Workplace Violence Prevention for Health Care and Social Service Workers Act ✓ Adopted Against
H.R. 1490: 504 Modernization and Small Manufacturer Enhancement Act ✓ Adopted For
H.R. 1487: Microloan Transparency and Accountability Act ✓ Adopted For
H.R. 1502: Microloan Improvement Act ✓ Adopted For
H.R. 1899: Ensuring Compliance Against Drug Diversion Act ✓ Adopted Against
H.R. 1002: Debarment Enforcement of Bad Actor Registrants Act ✓ Adopted Against
H.R. 1762: Protecting Indian Tribes from Scams Act ✓ Adopted For
H.R. 446: Protecting Seniors from Emergency Scams Act ✓ Adopted For
H.R. 941: TRANSPLANT Act ✓ Adopted For
H.R. 7: Paycheck Fairness Act ✓ Adopted Against
H.R. 1460: Nicholas and Zachary Burt Memorial Carbon Monoxide Poisoning Prevention Act ✓ Adopted Against
H.R. 1215: Fraud and Scam Reduction Act ✓ Adopted For
H.Res. 303: Providing for consideration of H.R. 7, the Paycheck Fairness Act and H.R. 1195, the Workplace Violence Prevention for Health Care and Social Service Workers Act ✓ Adopted Against
S. 164: Advancing Education on Biosimilars Act ✓ Adopted Against
S. 578: Food Allergy Safety, Treatment, Education, and Research Act ✓ Adopted Against
H.R. 172: United States Anti-Doping Agency Reauthorization Act ✓ Adopted Against
H.Res. 134: Condemning the military coup that took place on February 1, 2021, in Burma and the Burmese military detention of civilian leaders, calling for the release of all those detained and for those elected to serve Parliament to resume their duties, and for other purposes ✓ Adopted For
H.R. 1868: To prevent across-the-board direct spending cuts, and for other purposes ✓ Adopted Against
H.R. 1603: Farm Workforce Modernization Act ✓ Adopted Against
H.R. 6: Dream Act ✓ Adopted Against
H.R. 1652: VOCA Fix to Sustain the Crime Victims Fund Act ✓ Adopted Against
H.R. 1651: COVID-19 Bankruptcy Relief Extension Act ✓ Adopted For

Rows per page: 20 40 100 200